Foy J M, Nuhu S Z
Arch Int Pharmacodyn Ther. 1985 Feb;273(2):237-50.
Rat superior mesenteric vascular bed was isolated, perfused by the artery with Krebs solution and the perfusion pressure monitored. Dose-response curves to noradrenaline and KCl administered as bolus doses were obtained. A 1 hr continuous infusion of either piretanide (10 micrograms ml-1) frusemide (40 micrograms ml-1) or bumetanide (2 micrograms ml-1) decreased the sensitivity of the preparation to noradrenaline but not to KCl. This effect was antagonized by flurbiprofen (12 micrograms ml-1) pretreatment. A 1 hr continuous infusion of prostaglandin (PG)E2 increased the sensitivity of the preparation to both noradrenaline and KCl. PGI2 (5 ng bolus) or diuretic perfusion antagonized the responses to noradrenaline but not those to KCl. PGI2 and diuretics in combination further decreased the responsiveness of the preparation to noradrenaline. KCl responses were unaffected by either PGI2 or diuretics, alone or combined. The results suggest that the loop diuretics decrease the responsiveness of the isolated rat superior mesenteric vascular bed preparation to noradrenaline, possibly by increasing the level of PGI2, an effect which may be an important factor in the cardiovascular activity of the diuretics.
分离大鼠肠系膜上血管床,用动脉灌注 Krebs 溶液并监测灌注压力。获得去甲肾上腺素和氯化钾推注剂量的剂量反应曲线。连续 1 小时输注吡咯他尼(10 微克/毫升)、呋塞米(40 微克/毫升)或布美他尼(2 微克/毫升)可降低该制剂对去甲肾上腺素的敏感性,但不影响对氯化钾的敏感性。氟比洛芬(12 微克/毫升)预处理可拮抗此效应。连续 1 小时输注前列腺素(PG)E2 可增加该制剂对去甲肾上腺素和氯化钾的敏感性。前列环素(PGI2)(5 纳克推注)或利尿剂灌注可拮抗对去甲肾上腺素的反应,但不影响对氯化钾的反应。PGI2 和利尿剂联合使用可进一步降低该制剂对去甲肾上腺素的反应性。单独或联合使用 PGI2 或利尿剂均不影响氯化钾反应。结果表明,袢利尿剂可能通过增加 PGI2 水平来降低离体大鼠肠系膜上血管床制剂对去甲肾上腺素的反应性,这一效应可能是利尿剂心血管活性的重要因素。